Virtus Biotech Clinical Trials ETF
Virtus Biotech Clinical Trials ETF (BBC) Implied Volatility Current
BBC implied volatility is 40%. IV Rank is 31%, placing current premiums in the middle of their 52-week range.
Read more
Tracking BBC implied volatility helps you identify when options premiums on Virtus Biotech Clinical Trials ETF are historically cheap or expensive, and where the best trades are hiding. Virtus Biotech Clinical Trials ETF implied volatility reflects the market's expectation of future price movement: when BBC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Virtus Biotech Clinical Trials ETF's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For BBC, tracking metrics like BBC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on BBC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where BBC implied volatility sits today versus where it has been. Our scanner ranks Virtus Biotech Clinical Trials ETF implied volatility against its historical range, surfaces extremes in BBC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Virtus Biotech Clinical Trials ETF IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 16, 2026
Trade options with IV on your side
Track BBC IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→